Back to Sites University of Florida Jacksonville Site Number 5051 Address University of Florida Jacksonville 653-1 West 8th Street LRC 3rd Floor Jacksonville, FL 32209 United States of America IMPAACT Members at this Site Joseph Mims CAB Member Ana Alvarez Co-Investigator Bernadette Belgado Co-Investigator Feroz Bhinde Co-Investigator Peggy Borum Co-Investigator Denise Darracott Co-Investigator Carol Fulton Co-Investigator Nizar Maraqa Co-Investigator Ayesha Mirza Co-Investigator Elaine Poon Co-Investigator Saniyyah Mahmoudi CRS Coordinator Mobeen Rathore CRS Leader Michele Burke CRS Staff Angela Monroe CRS Staff Laura Armas-Kolostroubis Investigator Renette Dasher Investigator Isaac Delke Investigator Michael Miller Investigator Kristi Stowers Investigator Elizabeth Martino Laboratory Technician/Technologist Diane Swindell Research Assistant Geraldine (Geri) Thomas Research Nurse Mobeen Rathore Site Leader Margot Althuis-Brown Study Coordinator Indira Becerrit Study Coordinator Doriana Boro Study Coordinator Barbara Millwood Study Coordinator Studies at this Site A5241: Identifying Salvage Regimen w/ & w/o NRTIs Using cPSS and New Agents in the US DAIDS Number 10395 Research Area Antiretroviral Strategies Study Status Concluded A5257: Study of Three Compact ARV Regimens for Treatment of Naive HIV-1 Volunteers DAIDS Number 10670 Research Area Antiretroviral Strategies Study Status Concluded 1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival) DAIDS Number 10779 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded P1074: IMPAACT LTFU Study DAIDS Number 10660 Research Area Complications & Comorbidities Study Status Concluded P1097: Raltegravir PK Study DAIDS Number 11790 Research Area Treatment Study Status Concluded P1110: Safety and PK of RAL in Neonates DAIDS Number 11891 Research Area Treatment Study Status Concluded P1112: Monoclonal Antibody PK Study DAIDS Number 11903 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study DAIDS Number 11954 Research Area Cure and Immunotherapy Study Status Enrolling IMPAACT 2010: VESTED DAIDS Number 30129 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed Pagination Current page 1 Page 2 Next page Next
A5241: Identifying Salvage Regimen w/ & w/o NRTIs Using cPSS and New Agents in the US DAIDS Number 10395 Research Area Antiretroviral Strategies Study Status Concluded
A5257: Study of Three Compact ARV Regimens for Treatment of Naive HIV-1 Volunteers DAIDS Number 10670 Research Area Antiretroviral Strategies Study Status Concluded
1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival) DAIDS Number 10779 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded
P1074: IMPAACT LTFU Study DAIDS Number 10660 Research Area Complications & Comorbidities Study Status Concluded
P1110: Safety and PK of RAL in Neonates DAIDS Number 11891 Research Area Treatment Study Status Concluded
P1112: Monoclonal Antibody PK Study DAIDS Number 11903 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study DAIDS Number 11954 Research Area Cure and Immunotherapy Study Status Enrolling
IMPAACT 2010: VESTED DAIDS Number 30129 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed